DOI QR코드

DOI QR Code

Effect of Eicosapentaenoic Acid on Cellular Lipid Accumulation and Transcription Factors Involving Glucose Utilization

에이코사펜타에노익산에 의한 세포 내에서의 지방 축적 억제 효과 및 포도당 대사에 관여하는 전사인자의 변화

  • Bu, So-Young (Major in Food Science and Nutrition, School of Food Science, Kyungil University)
  • 부소영 (경일대학교 식품과학부 식품영양전공)
  • Received : 2011.08.25
  • Accepted : 2011.11.18
  • Published : 2011.12.31

Abstract

Previous studies suggest that polyunsaturated fatty acids with long carbon chains such as eicosapentaenoic acid(EPA) and docosahexaenoic acid(DHA) have several health benefits. However metabolic consequences of these fatty acids themselves and their regulation of transcriptional activity involving glucose utilization are not well established. Thus, the purpose of this study was to investigate how EPA influx affects cellular lipid accumulation and gene expressions involving $de$ $novo$ lipogenesis in hepatocyte cultures. Compared to oleic acid treatment, EPA treatment showed remarkably decreased cellular TG conversion and accumulation, along with phospholipids at a lower extent. As expected, EPA increased mRNA expression involving fatty acid influx and lipid droplet formation, but did not affect mRNA expression involving glucose utilization. EPA increased transcriptional activity of PPAR-${\alpha}$ and glucose responsive transcription factor when transcription factor binding protein was activated. Taken together, these data suggest that EPA decreases lipid accumulation through increases of the ${\beta}$-oxidation pathway without interruption of glucose utilization.

Keywords

References

  1. Bligh EG, Dyer WJ. 1959. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917 https://doi.org/10.1139/o59-099
  2. Bu SY, Mashek MT, Mashek DG. 2009. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity. J Biol Chem 284:30474-30483 https://doi.org/10.1074/jbc.M109.036665
  3. Chabowski A, Gorski J, Luiken JJ, Glatz JF, Bonen A. 2007. Evidence for concerted action of FAT/CD36 and FABP to increase fatty acid transport across the plasma membrane. Prostaglandins Leukot Essent Fatty Acids 77:345-353 https://doi.org/10.1016/j.plefa.2007.10.017
  4. Choe WK, Yoon OH, Kang BT. 1998. Effects of n-3 Polyunsaturated fatty acids on glucose uptake of soleus muscle in NIDDM diabetic rats. Korean J Food Nutr 11:550-555
  5. Elmadhoun BM, Wang GQ, Templeton JF, Burczynski FJ. 1998. Binding of [3H]palmitate to BSA. Am J Physiol 275:638- 644
  6. Fedor D, Kelley DS. 2009. Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care 12:138-146 https://doi.org/10.1097/MCO.0b013e3283218299
  7. Figueras M, Olivan M, Busquets S, López-Soriano FJ, Argilés JM. 2011. Effects of eicosapentaenoic acid(EPA) treatment on insulin sensitivity in an animal model of diabetes: improvement of the inflammatory status. Obesity(Silver Spring) 19:362-369
  8. Jay MA, Ren J. 2007. Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus. Curr Diabetes Rev 3:33-39 https://doi.org/10.2174/157339907779802067
  9. Kanaley JA, Shadid S, Sheehan MT, Guo Z, Jensen MD. 2009. Relationship between plasma free fatty acid, intramyocellular triglycerides and long-chain acylcarnitines in resting humans. J Physiol 587:5939-5950 https://doi.org/10.1113/jphysiol.2009.180695
  10. Kim DS, Ihm JG, Kim HD. 1999. Contents of polyunsaturated fatty acid in the pufferfish(Lagocephalus gloveri) liver oil. Korean J Food Nutr 12:113-118
  11. Klaunig JE, Goldblatt PJ, Hinton DE, Lipsky MM, Chacko J, Trump BF. 1981. Mouse liver cell culture. I. Hepatocyte isolation. In Vitro 17:913-925 https://doi.org/10.1007/BF02618288
  12. Li X, Hansen PA, Xi L, Chandraratna RA, Burant CF. 2005. Distinct mechanisms of glucose lowering effect by specific agonists for peroxisomal proliferator activated receptor gamma and retinoic acid X receptors. J Biological Chem 280:38317- 38327 https://doi.org/10.1074/jbc.M505853200
  13. McGill JB, Peterson LR, Herrero P, Saeed IM, Recklein C, Coggan AR, Demoss AJ, Schechtman KB, Dence CS, Gropler RJ. 2011. Potentiation of abnormalities in myocardial metabolism with the development of diabetes in women with obesity and insulin resistance. J Nucle Cardiol 18:421-429 https://doi.org/10.1007/s12350-011-9362-3
  14. Mori TA, Watts GF, Burke V, Hilme E, Puddey IB, Beilin LJ. 2000. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 102:1264-1269 https://doi.org/10.1161/01.CIR.102.11.1264
  15. Mori Y, Murakawa Y, Katoh S, Hata S, Yokoyama J, Tajima N, Ikeda Y, Nobukata H, Ishikawa T, Shibutani Y. 1997. Influence of highly purified eicosapentaenoic acid ethyl ester on insulin resistance in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus. Metabolism 46:1458-1464 https://doi.org/10.1016/S0026-0495(97)90148-7
  16. Morris KL, Namey TC, Zemel MB. 2003. Effects of dietary carbohydrate on the development of obesity in heterozygous Zucker rats. J Nutr Biochem 14:32-39 https://doi.org/10.1016/S0955-2863(02)00249-8
  17. Nam JH. 1994. Effects of dietary polyunsaturated fatty acids on tocopherol contents and lipid peroxidation of plasma and tissue in rats fed high fat diet. Korean J Food Nutr 7: 373-382
  18. Nettleton JA, Lutsey PL, Wang Y, Lima JA, Michos ED, Jacobs DR Jr. 2009. Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis(MESA). Diabetes Care 232:688-694
  19. Pawar A, Jump DB. 2003. Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor alpha activity in rat primary hepatocytes. J Biol Chem 278:35931-35939 https://doi.org/10.1074/jbc.M306238200
  20. Pawar A, Xu JH, Jerks E, Mangelsdorf DJ, Jump DB. 2002. Fatty acid regulation of liver X receptors(LXR) and peroxisome proliferator-activated receptor alpha(PPAR alpha) in HEK293 cells. J Biol Chem 277:39243-39250 https://doi.org/10.1074/jbc.M206170200
  21. Perez-Martinez P, Perez-Jimenez F, Lopez-Miranda J. 2010. n-3 PUFA and lipotoxicity. Biochim Biophys Acta 1801:362-366 https://doi.org/10.1016/j.bbalip.2009.09.010
  22. Reese-Wagoner A, Thompson J, Banaszak L. 1999. Structural properties of the adipocyte lipid binding protein. Biochim Biophys Acta 1441:106-116 https://doi.org/10.1016/S1388-1981(99)00154-7
  23. Repa JJ, Liang GS, Ou JF, Bashmakov Y, Lobaccaro JMA, Shimomura I, Shan B, Brown MS, Goldstein JL, Mangelsdorf DJ. 2000. Regulation of mouse sterol regulatory elementbinding protein-1c gene(SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Development 14:2819-2830 https://doi.org/10.1101/gad.844900
  24. Robbez Masson V, Lucas A, Gueugneau AM, Macaire JP, Paul JL, Grynberg, Rousseau D. 2008. Long-chain(n-3) polyunsaturated fatty acids prevent metabolic and vascular disorders in fructosefed rats. J Nutr 138:1915-1922 https://doi.org/10.1093/jn/138.10.1915
  25. Sapiro JM, Mashek MT, Greenberg AS, Mashek DG. 2009. Hepatic triacylglycerol hydrolysis regulates peroxisome proliferatoractivated receptor alpha activity. Lipid Res 50:1621-1629 https://doi.org/10.1194/jlr.M800614-JLR200
  26. Shoham DA, Durazo-Arvizu R, Kramer H, Luke A, Vupputuri S, Kshirsagar A, Cooper RS. 2008. Sugary soda consumption and albuminuria: Results from the National Health and Nutrition Examination Survey, 1999-2004. PLoS One 3: e3431 https://doi.org/10.1371/journal.pone.0003431
  27. Stoeckman AK, Ma L, Towle HC. 2004. Mlx is the functional heteromeric partner of the carbohydrate response element binding protein in glucose regulation of lipogenic enzyme genes. J Biol Chem 279:15662-15669 https://doi.org/10.1074/jbc.M311301200
  28. Xu J, Teran-Garcia M, Park JHY, Nakamura MT, Clarke SD. 2001. Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay. J Biol Chem 276:9800-9807 https://doi.org/10.1074/jbc.M008973200
  29. Zhang YL, Hernandez-Ono A, Siri P, Weisberg S, Conlon D, Graham MJ, Crooke RM, Huang LS, Ginsberg HN. 2006. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. J Biol Chem 281:37603- 37615 https://doi.org/10.1074/jbc.M604709200